24 October 2025 : Case report
Methotrexate-Induced Myelosuppression Due to Medication Error in an Elderly Patient with Rheumatoid Arthritis: A Case Report
Majd Mohammed AlqahtaniDOI: 10.12659/CPRM.950533
Med Sci Rev 2025; 12:e950533
Abstract
BACKGROUND: Methotrexate is the drug of choice for moderate to severe rheumatoid arthritis (RA), as recommended by American College of Rheumatology and European Alliance of Associations for Rheumatology guidelines, when no contraindications exist. These guidelines endorse methotrexate as a first-line treatment due to its efficacy in controlling disease activity and preventing joint damage, as well as for its cost-effectiveness. These guidelines emphasize the importance of regular monitoring and dose adjustments to minimize toxicity while maximizing therapeutic benefits. Despite its efficacy, complex dosing regimens can lead to medication errors, and overdose can result in severe hematologic and gastrointestinal toxicity.
CASE REPORT: This case report presents a 77-year-old Saudi woman with a history of RA, hypertension, hypothyroidism, lumbar spine stenosis, and gastroesophageal reflux disease, who mistakenly took methotrexate daily instead of weekly after confusing it with her daily dosing regimen for omeprazole. As a result, she experienced an adverse reaction to methotrexate, which led to pancytopenia, acute kidney injury, and elevated liver enzymes. She also experienced severe gastrointestinal symptoms, including abdominal pain, vomiting, diarrhea, and mucositis. Additionally, computed tomography imaging showed colonic inflammation, further indicating gastrointestinal involvement. The patient initially received an immediate platelet transfusion. Due to persistent pancytopenia, she subsequently received leucovorin rescue therapy and supportive treatment. Her condition improved, and she was discharged with a follow-up plan that included repeated complete blood count, liver function testing, and symptoms assessment.
CONCLUSIONS: This case underscores the importance of medication counseling and reconciliation for patients who are taking multiple medications, especially in the case of elderly individuals. It also underscores the need for increased awareness among healthcare providers regarding methotrexate dosing for RA, toxicity, and early intervention strategies in case of drug toxicity, to improve patient outcomes.
Keywords: Arthritis, Rheumatoid, Medication Errors, Methotrexate, Pancytopenia, Saudi Arabia
Most Viewed Current Articles
12 Nov 2021 : Review article
A Review of the Effects of Transurethral Microwave Thermotherapy (TUMT) for Lower Urinary Tract Symptoms (L...DOI :10.12659/CPRM.934690
Clin Prac Rev Met 2021; 8:e934690
10 Jan 2022 : Meta-Analysis
Antiproteinase-3 (PR3)-Antineutrophil Cytoplasmic Atibody (ANCA) as a Predictor for Relapse in Antineutroph...DOI :10.12659/CPRM.931261
Clin Prac Rev Met 2022; 9:e931261
21 Mar 2023 : Meta-Analysis
Comparison of Next-Generation Sequencing Versus Culture-Based Tests for Sepsis Pathogens Detection in the I...DOI :10.12659/CPRM.938643
Clin Prac Rev Met 2023; 10:e938643
07 Mar 2023 : Database Analysis
Visual Analysis of Research Trends and Hotspots in Traditional Chinese Medicine-Based Treatment of Chronic ...DOI :10.12659/CPRM.939445
Clin Prac Rev Met 2023; 10:e939445






